© 2001 European Society of Cardiology
Management of heart failure in Belgium
Cardiology Department, Braine l'Alleud-Waterloo Hospital, Free University of Brussels 35 rue Wayez, B1420 Braine, Belgium
* Corresponding author. Tel.: +32-23890453; fax: +32-3890312. E-mail address: bcosyns@arcadis.be (B. Cosyns).
Received September 15, 2000; Revised November 13, 2000; Accepted January 17, 2001
| The first 150 words of the full text of this article appear below. |
| 1. Introduction |
|---|
The overall population in Belgium is estimated to be approximately 11 000 000 people. In 1995, 15% of the population were more than 65 years of age. Heart failure in Belgium, as in other countries, is a common, disabling and lethal condition, which represents a major economic burden for the public health sector. Direct costs incurred by heart failure represent 1–2% of the total expenditure of the public health sector. The percentage of these costs, linked to hospitalisations, is more than 60% and the cost of medication is nearly 6%. The costs are a function of the severity of heart failure. The evaluation of the severity and incidence of heart failure remains difficult because of the lack of agreed definition, making its diagnosis difficult. What we know is that the incidence and prevalence of the heart failure syndrome are increasing in our greying population. Based on the Diagnostic Related Groups
| 2. Overview of the organisation of the health care system |
|---|
| 3. Management of heart failure by doctors |
|---|
3.1. Asymptomatic chronic heart failure
3.1.1. Treatment
3.2. Symptomatic chronic heart failure
| 4. Acute heart failure |
|---|
| 5. Diastolic heart failure |
|---|
| 6. Conclusions |
|---|